Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06784531 · ClinicalTrials.gov registry record · NA
The Influence of Race and MitoQ Supplementation on Skin Blood Flow in the Cold
A NA study of Cold Exposure, sponsored by United States Army Research Institute of Environmental Medicine.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06784531 is a NA study of Cold Exposure that is active but no longer recruiting, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 30 participants, below the 56-participant average among 3 other Cold Exposure trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06784531, a NA study of Cold Exposure, is active but no longer recruiting, sponsored by United States Army Research Institute of Environmental Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Individuals who operate in cold weather are at risk of developing cold injuries, for example, frostbite. They also often experience a loss of hand function and joint mobility due to a decrease in skin temperature and blood flow. In addition, the risk of getting a cold injury is higher in the Black population compared to other racial and ethnic groups. Increases in oxidant compounds can cause the blood vessels in the skin to narrow and decrease skin temperature in the cold. However, it is unknown whether the higher risk of cold injury in Black individuals is because of a greater amount of oxidant compounds in the blood vessels. The purpose of this research is to see if an antioxidant supplement called MitoQ can help to improve skin temperature and blood flow in the cold and if the improvement is greater in Black individuals.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Mitoquinone mesylate (MitoQ)
- OTHER Cold Water Hand Immersion
- OTHER Cold Air Exposure
Study Locations (1)
Massachusetts
- U.S. Army Research Institute of Environmental Medicine - Natick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-09-16 |
| Est. Completion | 2026-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06784531
The ClinicalTrials.gov registry entry for NCT06784531 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 56-participant average among 3 other Cold Exposure trials with a reported enrollment target (46% lower). The listed sponsor is United States Army Research Institute of Environmental Medicine, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cold Exposure appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT06784531 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06784531 about?
NCT06784531 is a clinical study titled "The Influence of Race and MitoQ Supplementation on Skin Blood Flow in the Cold". Individuals who operate in cold weather are at risk of developing cold injuries, for example, frostbite. They also often experience a loss of hand function and joint mobility due to a decrease in skin temperature and blood flow. In addition, the risk of getting a cold injury is higher in the Black ...
What is the current status of trial NCT06784531?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-09-16. Estimated completion is 2026-01.
What conditions does trial NCT06784531 study?
This clinical trial studies the following conditions: Cold Exposure.
What interventions are being tested in trial NCT06784531?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Mitoquinone mesylate (MitoQ) (DIETARY_SUPPLEMENT), Cold Water Hand Immersion (OTHER), Cold Air Exposure (OTHER).
Who is sponsoring clinical trial NCT06784531?
This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06784531 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cold Exposure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.